Literature DB >> 4197826

The immune response to thetaX 174 in man. I. Primary and secondary antibody production in normal adults.

D B Peacock, J V Jones, M Gough.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4197826      PMCID： PMC1553730     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  17 in total

1.  ANTIGENS OF BACTERIOPHAGE PHI-X174.

Authors:  U ROLFE; R L SINSHEIMER
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation.

Authors:  J E Curtis; E M Hersh; J E Harris; C McBride; E J Freireich
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

3.  Immunoglobulin classes of antibodies produced in the primary and secondary responses in man.

Authors:  K K Bandilla; F C McDuffie; G J Gleich
Journal:  Clin Exp Immunol       Date:  1969-12       Impact factor: 4.330

Review 4.  Genetic control of specific immune responses.

Authors:  H O McDevitt; B Benacerraf
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

5.  The serum antibody response to bacteriophage phi chi 174 in germ-free and conventionally reared mice. I. Assay of neutralizing antibody by a 50 per cent neutralization method.

Authors:  P W Stashak; P J Baker; B S Roberson
Journal:  Immunology       Date:  1970-02       Impact factor: 7.397

6.  Measurement of antibody-producing capacity in man. I. The normal response to flagellin from Salmonella adelaide.

Authors:  M J Rowley; I R Mackay
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

Review 7.  The kinetics of antibody formation.

Authors:  J W Uhr; M S Finkelstein
Journal:  Prog Allergy       Date:  1967

8.  Inactivation of bacteriophage T4, of poly-D-alanyl bacteriophage and of penicilloyl bacteriophage by immunospecifically isolated IgM and IgG antibodies.

Authors:  J Haimovich; M Sela
Journal:  J Immunol       Date:  1969-07       Impact factor: 5.422

9.  The occurrence of natural antibodies in sarcoidosis.

Authors:  L O Kallings; S Löfgren
Journal:  Acta Med Scand Suppl       Date:  1964

10.  Antibody formation. V. The avidity of gamma-M and gamma-G guinea pig antibodies to bacteriophage phi-x 174.

Authors:  M S Finkelstein; J W Uhr
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422
View more
  19 in total

1.  The immune response to phi chi 174 in man. II. Primary and secondary antibody production in patients with Crohn's disease.

Authors:  R C Bucknall; J V Jones; D B Peacock
Journal:  Am J Dig Dis       Date:  1975-05

2.  PhiXing-it, displaying foreign peptides on bacteriophage ΦX174.

Authors:  Kristofer J Christakos; Janice A Chapman; Bentley A Fane; Samuel K Campos
Journal:  Virology       Date:  2015-12-03       Impact factor: 3.616

3.  Antibody producing capacity to the bacteriophage phi X174 in rheumatoid arthritis.

Authors:  R Bucknall; P Bacon; C Elson; J V Jones
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

4.  Antibody to bacteriophage phi X 174 synthesized by cultured human peripheral blood lymphocytes.

Authors:  J Bohnsack; H D Ochs; R J Wedgwood; S R Heller
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

5.  Assessment of antibody-producing capacity in man.

Authors:  J V Jones
Journal:  Proc R Soc Med       Date:  1974-12

6.  Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.

Authors:  R Bucknall; M Leirisalo-Repo; O Laitinen; J V Jones
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

7.  Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosis.

Authors:  H C Thomas; R Holden; J V Jones; D B Peacock
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

8.  The immune response to phichi174 in man. IV. Primary and secondary antibody production in patients with chronic lymphatic leukaemia.

Authors:  T J Hamblin; J V Jones; D B Peacock
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

9.  Factors influencing the secondary antibody response to flagellin in man.

Authors:  S Whittingham; J D Buckley; I R Mackay
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

10.  Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.

Authors:  Marc C Levesque; M Anthony Moody; Kwan-Ki Hwang; Dawn J Marshall; John F Whitesides; Joshua D Amos; Thaddeus C Gurley; Sallie Allgood; Benjamin B Haynes; Nathan A Vandergrift; Steven Plonk; Daniel C Parker; Myron S Cohen; Georgia D Tomaras; Paul A Goepfert; George M Shaw; Jörn E Schmitz; Joseph J Eron; Nicholas J Shaheen; Charles B Hicks; Hua-Xin Liao; Martin Markowitz; Garnett Kelsoe; David M Margolis; Barton F Haynes
Journal:  PLoS Med       Date:  2009-07-07       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.